4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-21-020548
Director sold 18,000 shares at $35.02 ($630,360)
- Director acquired 18,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KEARNS THOMAS F JR · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-11 | Exercise or conversion : show line 1 in the form | +18,000 | $3.50 | $63,000 | 166,164 | D |
| 2021-03-11 | Sale : show line 2 in the form | −18,000 | $35.02 | $630,360 | 148,164 | D |
| Open-market sales · 18,000 sh · avg $35.02 · $630,360 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-11 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −12,000 | 0 | D |
| 2021-03-11 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −6,000 | 0 | D |
Loading xslF345X03/doc4.xml…